{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:28:32Z","timestamp":1744194512383},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary aldosteronism (PA) is mainly clinically classified as unilateral aldosterone-producing adenoma (APA) or bilateral idiopathic hyperaldosteronism. Immunohistochemistry for aldosterone synthase reveals a diverse PA pathology, including pathological APA and aldosterone-producing cell clusters. The relationship between PA pathology and adrenalectomy outcomes was examined herein. Data from 219 unilaterally adrenalectomized PA cases were analyzed. Pathological analyses revealed diverse putative aldosterone-producing lesions. Postoperative biochemical outcomes in 114 cases (test cohort) were classified as complete success (<jats:italic>n<\/jats:italic>\u2009=\u200985), partial success (<jats:italic>n<\/jats:italic>\u2009=\u200919), and absent success (<jats:italic>n<\/jats:italic>\u2009=\u200910). Outcomes in the large and small PA lesion groups, rather than between PA lesion types, were compared at five threshold values for PA lesion sizes (2\u20136\u2009mm with 1-mm increments) to streamline the results. The proportion of complete success was significantly higher in the large PA lesion group than in the small PA lesion group at the 5-mm threshold only. The proportion of absent success was significantly higher in the small PA lesion group than in the large PA lesion group at all thresholds. Univariate and multivariate analyses of the test cohort identified serum K as an independent predictive factor for the small PA lesion group, which was confirmed in the 105-case validation cohort. Chi-squared automatic interaction detector analysis revealed that the best threshold of serum K for predicting large PA lesions was 2.82\u2009mEq\/L. These results will be beneficial for treating PA in clinical settings because patients with low serum K levels and apparent adrenal masses on CT may be subjected to adrenalectomy even if the adrenal venous sampling test is unavailable.<\/jats:p>","DOI":"10.1038\/s41440-020-00579-w","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T12:09:11Z","timestamp":1610453351000},"page":"498-507","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diverse pathological lesions of primary aldosteronism and their clinical significance"],"prefix":"10.1038","volume":"44","author":[{"name":"JRAS Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshiro","family":"Nishimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Umakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsugio","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichiro","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuyuki","family":"Katabami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Sone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichiro","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozo","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Tsuiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhide","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"579_CR1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","volume":"71","author":"Y Ohno","year":"2018","unstructured":"Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, et al. Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension. 2018;71:530\u20137.","journal-title":"Hypertension"},{"key":"579_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41440-018-0126-1","volume":"42","author":"R Okamoto","year":"2019","unstructured":"Okamoto R, Taniguchi M, Onishi Y, Kumagai N, Uraki J, Fujimoto N, et al. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study. Hypertens Res. 2019;42:40\u201351.","journal-title":"Hypertens Res"},{"key":"579_CR3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"579_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41440-019-0244-4","volume":"42","author":"M Satoh","year":"2019","unstructured":"Satoh M, Maruhashi T, Yoshida Y, Shibata H. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism. Hypertens Res. 2019;42:817\u201324.","journal-title":"Hypertens Res"},{"key":"579_CR5","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1210\/jc.2009-2010","volume":"95","author":"K Nishimoto","year":"2010","unstructured":"Nishimoto K, Nakagawa K, Li D, Kosaka T, Oya M, Mikami S, et al. Adrenocortical zonation in humans under normal and pathological conditions. J Clin Endocrinol Metab. 2010;95:2296\u2013305.","journal-title":"J Clin Endocrinol Metab"},{"key":"579_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1210\/jc.2015-3285","volume":"101","author":"K Nishimoto","year":"2016","unstructured":"Nishimoto K, Seki T, Kurihara I, Yokota K, Omura M, Nishikawa T, et al. Case report: nodule development from subcapsular aldosterone-producing cell clusters causes hyperaldosteronism. J Clin Endocrinol Metab. 2016;101:6\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"579_CR7","doi-asserted-by":"publisher","first-page":"105361","DOI":"10.1016\/j.jsbmb.2019.04.010","volume":"191","author":"T Hayashi","year":"2019","unstructured":"Hayashi T, Zhang Z, Al-Eyd G, Sasaki A, Yasuda M, Oyama M, et al. Expression of aldosterone synthase CYP11B2 was inversely correlated with longevity. J Steroid Biochem Mol Biol. 2019;191:105361.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"579_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.mce.2016.10.014","volume":"441","author":"K Nishimoto","year":"2017","unstructured":"Nishimoto K, Koga M, Seki T, Oki K, Gomez-Sanchez EP, Gomez-Sanchez CE, et al. Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism. Mol Cellular Endocrinol. 2017;441:124\u201333.","journal-title":"Mol Cellular Endocrinol"},{"key":"579_CR9","doi-asserted-by":"publisher","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","volume":"112","author":"K Nishimoto","year":"2015","unstructured":"Nishimoto K, Tomlins SA, Kuick R, Cani AK, Giordano TJ, Hovelson DH, et al. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Nat Acad Sci USAm. 2015;112:E4591\u20134599.","journal-title":"Proc Nat Acad Sci USAm"},{"key":"579_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/MNH.0000000000000487","volume":"28","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Sugiura Y, Mune T, Nishiyama M, Terada Y, Mukai K, et al. Immunohistochemistry for aldosterone synthase CYP11B2 and matrix-assisted laser desorption ionization imaging mass spectrometry for in-situ aldosterone detection. Curr Opin Nephrol Hypertens. 2019;28:105\u201312.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"579_CR11","first-page":"1182","volume":"102","author":"Y Yamazaki","year":"2017","unstructured":"Yamazaki Y, Nakamura Y, Omata K, Ise K, Tezuka Y, Ono Y, et al. Histopathological classification of cross-sectional image-negative hyperaldosteronism. J Clin Endocrinol Metab. 2017;102:1182\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"579_CR12","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"579_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689\u201399.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"579_CR14","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1038\/s41440-019-0310-y","volume":"42","author":"D Aono","year":"2019","unstructured":"Aono D, Kometani M, Karashima S, Usukura M, Gondo Y, Hashimoto A, et al. Primary aldosteronism subtype discordance between computed tomography and adrenal venous sampling. Hypertens Res. 2019;42:1942\u201350.","journal-title":"Hypertens Res"},{"key":"579_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1210\/er.2017-00189","volume":"38","author":"MC Zennaro","year":"2017","unstructured":"Zennaro MC, Boulkroun S, Fernandes-Rosa F. Genetic causes of functional adrenocortical adenomas. Endocrine reviews. 2017;38:516\u201337.","journal-title":"Endocrine reviews"},{"key":"579_CR16","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/HYPERTENSIONAHA.119.14041","volume":"75","author":"N Sun","year":"2020","unstructured":"Sun N, Meyer LS, Feuchtinger A, Kunzke T, Kn\u00f6sel T, Reincke M, et al. Mass spectrometry imaging establishes 2 distinct metabolic phenotypes of aldosterone-producing cell clusters in primary aldosteronism. Hypertension. 2020;75:634\u201344.","journal-title":"Hypertension"},{"key":"579_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/pin.12521","volume":"67","author":"A Ito","year":"2017","unstructured":"Ito A, Yamazaki Y, Sasano H, Matsubara D, Fukushima N, Tamba M, et al. A case of primary aldosteronism caused by unilateral multiple adrenocortical micronodules presenting as muscle cramps at rest: the importance of functional histopathology for identifying a culprit lesion. Pathol Int. 2017;67:214\u201321.","journal-title":"Pathol Int"},{"key":"579_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.4158\/EP15982.OR","volume":"22","author":"T Kocjan","year":"2016","unstructured":"Kocjan T, Janez A, Stankovic M, Vidmar G, Jensterle MA. New clinical prediction criterion accurately determines a subset of patients with bilateral primary aldosteronism before adrenal venous sampling. Endocr Pract. 2016;22:587\u201394.","journal-title":"Endocr Pract"},{"key":"579_CR19","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1210\/jc.2012-1917","volume":"97","author":"EM Kupers","year":"2012","unstructured":"Kupers EM, Amar L, Raynaud A, Plouin PF, Steichen O. A clinical prediction score to diagnose unilateral primary aldosteronism. J Clin Endocrinol Metab. 2012;97:3530\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"579_CR20","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/jhh.2014.20","volume":"28","author":"K Nanba","year":"2014","unstructured":"Nanba K, Tsuiki M, Nakao K, Nanba A, Usui T, Tagami T, et al. A subtype prediction score for primary aldosteronism. J Hum Hypertens. 2014;28:716\u201320.","journal-title":"J Hum Hypertens"},{"key":"579_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/cen.13278","volume":"86","author":"H Kobayashi","year":"2017","unstructured":"Kobayashi H, Haketa A, Ueno T, Ikeda Y, Hatanaka Y, Tanaka S, et al. Scoring system for the diagnosis of bilateral primary aldosteronism in the outpatient setting before adrenal venous sampling. Clin Endocrinol (Oxf). 2017;86:467\u201372.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"579_CR22","first-page":"55716","volume":"127","author":"K Makita","year":"2017","unstructured":"Makita K, Nishimoto K, Kiriyama-Kitamoto K, Karashima S, Seki T, Yasuda M, et al. A novel method: super-selective adrenal venous sampling. J Vis Exp. 2017;127:55716.","journal-title":"J Vis Exp"},{"key":"579_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mce.2016.07.031","volume":"441","author":"A Tamura","year":"2017","unstructured":"Tamura A, Nishimoto K, Seki T, Matsuzawa Y, Saito J, Omura M, et al. Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism. Mol Cellular Endocrinol. 2017;441:134\u20139.","journal-title":"Mol Cellular Endocrinol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-00579-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-00579-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-020-00579-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:22:58Z","timestamp":1684617778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-020-00579-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1038\/s41440-020-00579-w","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"type":"print","value":"0916-9636"},{"type":"electronic","value":"1348-4214"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"11 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}